Valuation: Maravai LifeSciences Holdings, Inc.

Market Cap 1.05B 921M 856M 787M 1.48B 101B 1.5B 10.23B 3.99B 49.47B 3.93B 3.85B 172B P/E 2026 *
-22.9x
P/E 2027 * -30.5x
Enterprise Value 1.06B 933M 867M 797M 1.49B 103B 1.52B 10.36B 4.04B 50.1B 3.98B 3.9B 174B EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.49x
Free-Float
41.44%
Yield 2026 *
-
Yield 2027 * -
1 day-0.70%
1 week-0.56%
Current month+12.98%
1 month+31.28%
3 months+104.35%
6 months+90.03%
Current year+116.92%
1 week 6.74
Extreme 6.74
7.44
1 month 5.46
Extreme 5.46
7.44
Current year 2.8
Extreme 2.8
7.44
1 year 1.99
Extreme 1.99
7.44
3 years 1.66
Extreme 1.665
12.56
5 years 1.66
Extreme 1.665
63.55
10 years 1.66
Extreme 1.665
63.55
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-07
Director of Finance/CFO 59 2025-06-29
Chief Operating Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 50 2016-02-29
Director/Board Member 65 2020-10-31
Director/Board Member 61 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
7/8/26 Tax

Chief Executive Officer

-29,250 0.0198%
6/30/26 Tax

Chief Financial Officer

-65,584 0.0445%
6/10/26 Sell

General Counsel

-25,000 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
-0.70%-0.56%+169.08%-43.51% 1.05B
-0.22%-2.26%+139.07%+110.17% 4.63B
+1.64%+0.95%+105.24%+186.03% 3.51B
-0.77%+10.09%+29.22%-30.39% 2.31B
-1.76%-1.45%-27.07%-36.48% 2.13B
-0.45%-6.77%+186.66%+261.29% 1.95B
+2.42%-5.81%-8.77%+28.14% 830M
+0.67%-1.89%-36.38%-13.58% 494M
+6.72%-12.13%-7.56% - 407M
+5.44%-14.89% - - 158M
Average +1.30%+0.93%+61.06%+57.71% 1.75B
Weighted average by Cap. +0.20%+2.53%+88.79%+88.58%

Financials

2026 *2027 *
Net sales 210M 185M 172M 158M 297M 20.38B 302M 2.06B 802M 9.94B 790M 773M 34.48B 226M 199M 185M 170M 318M 21.87B 324M 2.21B 861M 10.67B 848M 830M 37.01B
Net income -39.2M -34.47M -32.02M -29.45M -55.24M -3.8B -56.23M -383M -149M -1.85B -147M -144M -6.42B -28.2M -24.8M -23.04M -21.19M -39.74M -2.73B -40.45M -276M -107M -1.33B -106M -104M -4.62B
Net Debt 13.46M 11.83M 10.99M 10.11M 18.96M 1.3B 19.3M 131M 51.28M 636M 50.52M 49.43M 2.21B -33.46M -29.43M -27.34M -25.15M -47.16M -3.24B -48M -327M -128M -1.58B -126M -123M -5.48B
Logo Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc. is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.
Employees
416
Date Price Change Volume
26-07-23 US$7.050 -0.70% 2,157,946
26-07-22 US$7.100 0.00% 2,413,025
26-07-21 US$7.100 +1.57% 2,833,475
26-07-20 US$6.990 -3.45% 2,302,924
26-07-17 US$7.240 +2.12% 2,845,187
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.100USD
Average target price
5.900USD
Spread / Average Target
-16.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRVI Stock